✨ New Arrivals Just Dropped!Explore
HomeStore

Respiratory Test Kit Quickvue® Covid-19 Test 2 Tests Clia Waived

Product image 1
1 / 2

Respiratory Test Kit Quickvue® Covid-19 Test 2 Tests Clia Waived

  • QuickVue At-Home OTC COVID-19 Test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) under the new name – QuickVue COVID-19 Test
  • The QuickVue COVID-19 Test is a visually read lateral flow immunoassay device intended for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigens directly in anterior nasal (nares) swab specimens from individuals with signs and symptoms of COVID-19 within the first 5 days from symptom onset
  • This test is for non-prescription home use by individuals aged 14 years or older testing themselves, or adults testing individuals aged 2 years or older
  • The QuickVue COVID-19 Test does not differentiate between SARS-CoV and SARS-CoV-2
  • All negative results are presumptive
  • Negative results do not preclude SARS-CoV-2 infections or other pathogens and should not be used as the sole basis for treatment
  • Positive results do not rule out co-infection with other respiratory pathogens
  • QuickVue At-Home OTC COVID-19 Test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) under the new name – QuickVue COVID-19 Test
  • The QuickVue COVID-19 Test is a visually read lateral flow immunoassay device intended for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigens directly in anterior nasal (nares) swab specimens from individuals with signs and symptoms of COVID-19 within the first 5 days from symptom onset
  • This test is for non-prescription home use by individuals aged 14 years or older testing themselves, or adults testing individuals aged 2 years or older
  • The QuickVue COVID-19 Test does not differentiate between SARS-CoV and SARS-CoV-2
  • All negative results are presumptive
  • Negative results do not preclude SARS-CoV-2 infections or other pathogens and should not be used as the sole basis for treatment
  • Positive results do not rule out co-infection with other respiratory pathogens
Select Packaging
From $6.88

Original: $22.95

-70%
Respiratory Test Kit Quickvue® Covid-19 Test 2 Tests Clia Waived—

$22.95

$6.88

Description

  • QuickVue At-Home OTC COVID-19 Test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) under the new name – QuickVue COVID-19 Test
  • The QuickVue COVID-19 Test is a visually read lateral flow immunoassay device intended for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigens directly in anterior nasal (nares) swab specimens from individuals with signs and symptoms of COVID-19 within the first 5 days from symptom onset
  • This test is for non-prescription home use by individuals aged 14 years or older testing themselves, or adults testing individuals aged 2 years or older
  • The QuickVue COVID-19 Test does not differentiate between SARS-CoV and SARS-CoV-2
  • All negative results are presumptive
  • Negative results do not preclude SARS-CoV-2 infections or other pathogens and should not be used as the sole basis for treatment
  • Positive results do not rule out co-infection with other respiratory pathogens